Screener
Elevance Health ELV EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Elevance Health in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Elevance Health’s 10-Q, filed July 15, 2026.
- Filed
- Jul 15, 2026, 11:27 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001156039-26-000060
| Line item | Three Months Ended June 30 / 2026 | Three Months Ended June 30 / 2025 | Six Months Ended June 30 / 2026 | Six Months Ended June 30 / 2025 |
|---|---|---|---|---|
| Income tax expense | 483 | 548 | 1,027 | 1,161 |
| Net income | 1,454 | 1,744 | 3,214 | 3,928 |
| Net loss (gain) attributable to noncontrolling interests | 9 | (1) | 13 | (2) |
| Shareholders’ net income | $1,463 | $1,743 | $3,227 | $3,926 |
| Shareholders’ net income per share | ||||
| Basic | $6.74 | $7.74 | $14.78 | $17.39 |
| Diluted | $6.71 | $7.72 | $14.73 | $17.33 |
| Dividends per share | $1.72 | $1.71 | $3.44 | $3.42 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Elevance Health's EPS (diluted)?
- Elevance Health (ELV) reported EPS (diluted) of $6.71 in Q2 2026.
- How has Elevance Health's EPS (diluted) changed year-over-year?
- Elevance Health's EPS (diluted) decreased by 13.1% year-over-year, from $7.72 to $6.71.
- What is the long-term trend for Elevance Health's EPS (diluted)?
- Over 4 years (2021 to 2025), Elevance Health's EPS (diluted) has grown at a 0.2% compound annual growth rate (CAGR), from $24.95 to $25.19.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Elevance Health's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude